54408 Federal Register / Vol. 73, No. 183 / Friday, September 19, 2008 / Notices 

1Coordinated Framework for the Regulation of 

Biotechnology: June 26, 1986; 51 FR 23302; http:// 

usbiotechreg.nbii.gov/CoordinatedFrameworkFor

RegulationOfBiotechnology1986.pdf. 

2In addition to discussing the regulatory 

responsibilities of these agencies for GE organisms 

and other products, the Coordinated Framework 

also discusses the responsibilities of agencies with 

jurisdiction over GE research (the National 

Institutes of Health, the National Science 

Foundation, the Environmental Protection Agency 

(EPA), and the U.S Department of Agriculture’s 

(USDA’s) Agricultural Research Service). 

same way as described in this guidance 

for heritable constructs, this guidance 

only pertains to GE animals containing 

heritable rDNA constructs. We may 

issue a separate guidance on the 

regulation of GE animals bearing nonheritable constructs to discuss when 

those constructs would be under FDA 

jurisdiction and the kinds of 

information that would be relevant for 

FDA’s review. 

FDA’s authority over new animal 

drugs comes from the Federal Food, 

Drug, and Cosmetic Act. The definition 

of a drug, in section 201(g) of the act (21 

U.S.C. 321(g)), includes ‘‘articles 

intended for use in the diagnosis, cure, 

mitigation, treatment, or prevention of 

disease in man or other animals;’’ and 

‘‘articles (other than food) intended to 

affect the structure or any function of 

the body of man or other animals.’’ The 

rDNA construct in a GE animal that is 

intended to affect the structure or 

function of the body of the GE animal, 

regardless of the intended use of 

products that may be produced by the 

GE animal, meets the act drug 

definition. The draft guidance describes 

how the new animal drug provisions of 

the act apply with respect to GE 

animals, including FDA’s intent to 

exercise enforcement discretion 

regarding requirements for certain GE 

animals. 

FDA is one of several Federal agencies 

that share regulatory oversight of GE 

organisms. In 1986, the Office of 

Science and Technology Policy (OSTP) 

under the Executive Office of the 

President published a policy document 

known as the Coordinated Framework 

for the Regulation of Biotechnology (the 

Coordinated Framework).1 This policy 

document describes the system for 

coordinating the activities of the Federal 

agencies responsible for regulating all 

GE organisms.2

In addition to FDA’s role in oversight 

of GE animals, APHIS is authorized, 

under the AHPA (7 U.S.C. 8301 et seq.), 

to protect the health of U.S. livestock by 

preventing the introduction and spread 

of livestock diseases and pests into and 

within the United States. Based on that 

authority, APHIS may broadly consider 

the potential effects of animals with GE 

traits on the health of the overall U.S. 

livestock population, while FDA is more 

focused on the direct effects of genetic 

engineering on individual animals 

based on its authority under the act. 

Given these complementary authorities, 

FDA and APHIS have been discussing 

their respective roles in overseeing GE 

animals for some time. In conjunction 

with FDA’s release for public comment 

of its guidance on GE animals, APHIS is 

soliciting public comment in this same 

issue of the Federal Register on any 

potential implications of activities such 

as the importation or interstate 

movement of GE animals on the health 

of the U.S. livestock population. 

II. Significance of Guidance 

This Level 1 draft guidance is being 

issued consistent with FDA’s Good 

Guidance Practices regulation (21 CFR 

10.115). This draft guidance, when 

finalized, will represent the agency’s 

current thinking on the topic. It does not 

create or confer any rights for or on any 

person and does not operate to bind 

FDA or the public. An alternative 

method may be used as long as it 

satisfies the requirements of applicable 

statutes and regulations. 

III. Paperwork Reduction Act of 1995 

This draft guidance refers to 

previously approved collections of 

information found in FDA regulations. 

These collections of information are 

subject to review by the Office of 

Management and Budget (OMB) under 

the Paperwork Reduction Act of 1995 

(44 U.S.C. 3501–3520). The collections 

of information have been approved 

under OMB Control Nos. 0910–0032, 

0910–0045, 0910–0117, and 0910–0284. 

FDA seeks public comment on the 

agency’s determination that the 

previously approved collections of 

information referred to previously 

adequately account for the collections of 

information referenced in this guidance. 

Although the collections of information 

burden estimates previously approved 

by OMB were derived for new animal 

drug applications (NADAs) in general, 

FDA believes that such estimates are 

applicable to NADAs for GE animals. In 

particular, FDA previously determined 

that preparing the paperwork required 

for an NADA under 21 CFR 514.1 will 

take approximately 212 hours. Over the 

past 5 fiscal years, FDA has received an 

average of 19 NADAs per year. 

IV. Comments 

Interested persons may submit to the 

Division of Dockets Management (see 

ADDRESSES) written or electronic 

comments regarding this document. 

Submit a single copy of electronic 

comments or two paper copies of any 

mailed comments, except that 

individuals may submit one paper copy. 

Comments are to be identified with the 

docket number found in brackets in the 

heading of this document. Received 

comments may be seen in the Division 

of Dockets Management between 9 a.m. 

and 4 p.m., Monday through Friday. 

Please note that on January 15, 2008, 

the FDA Division of Dockets 

Management Web site transitioned to 

the Federal Dockets Management 

System (FDMS). FDMS is a 

Government-wide, electronic docket 

management system. Electronic 

comments or submissions will be 

accepted by FDA only through FDMS at 

http://www.regulations.gov. 

V. Electronic Access 

Persons with access to the Internet 

may obtain the draft guidance at either 

http://www.fda.gov/cvm or http:// 

www.regulations.gov. 

Dated: September 15, 2008. 

Jeffrey Shuren, 

Associate Commissioner for Policy and 

Planning. 

[FR Doc. E8–21917 Filed 9–18–08; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(cX4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Oncological Sciences 

Integrated Review Group, Cancer Etiology 

Study Section. 

Date: September 29–30, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hotel Nikko San Francisco, 222 

Mason Street, San Francisco, CA 94102. 

Contact Person: Najma Begum, PhD, 

Scientific Review Officer, Center for 


jlentini on PROD1PC65 with NOTICES
Federal Register / Vol. 73, No. 183 / Friday, September 19, 2008 / Notices 54409 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2186, 

MSC 7818, Bethesda, MD 20892, 301–435– 

1243, begumn@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Virology-B. 

Date: October 2, 2008. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Sheraton Fisherman’s Wharf Hotel, 

2500 Mason Street, San Francisco, CA 94133. 

Contact Person: Soheyla Saadi, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3211, 

MSC 7808, Bethesda, MD 20892, 301–435– 

0903, saadisoh@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Social 

Sciences and Population Studies R21s, R03s. 

Date: October 3, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Brookshire Suites, 120 E. Lombard 

Street, Baltimore, MD 21202. 

Contact Person: Denise Wiesch, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3150, 

MSC 7770, Bethesda, MD 20892, (301) 435– 

0684, wieschd@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Oncology 

and Therapeutics. 

Date: October 6, 2008. 

Time: 9:30 a.m. to 11:30 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call) 

Contact Person: Angela V. Ng, PhD, MBA., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6200, 

MSC 7804, (For courier delivery, use MD 

20817), Bethesda, MD 20892, 301–435–1715, 

nga@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Vascular 

Pathobiology. 

Date: October 7–8, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Virtual Meeting) 

Contact Person: Ai-Ping Zou, MD, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4118, 

MSC 7814, Bethesda, MD 20892, 301–435– 

1777, zouai@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflict: Addiction and Memory. 

Date: October 7–8, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Virtual Meeting) 

Contact Person: Brian Hoshaw, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5181, 

MSC 7844, Bethesda, MD 20892, 301–435– 

1033, hoshawb@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Psychiatric 

Genetics. 

Date: October 7, 2008. 

Time: 8:30 a.m. to 9 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: St. Gregory Hotel, 2033 M Street, 

NW., Washington, DC 20036. 

Contact Person: Cheryl M. Corsaro, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2204, 

MSC 7890, Bethesda, MD 20892, (301) 435– 

1045, corsaroc@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, SAT 

Member Conflict. 

Date: October 7, 2008. 

Time: 2 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Virtual Meeting) 

Contact Person: Roberto J. Matus, MD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5108, 

MSC 7854, Bethesda, MD 20892, 301–435– 

2204, matusr@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Vector 

Biology. 

Date: October 8, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bolger Center, 9600 Newbridge 

Drive, Potomac, MD 20854. 

Contact Person: John C. Pugh, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 1206, 

MSC 7808, Bethesda, MD 20892, 301–435– 

2398, pughjohn@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Brain Disorders and 

Clinical Neuroscience Integrated, Review 

Group Developmental Brain Disorders Study 

Section. 

Date: October 9–10, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Melrose Hotel, 2430 Pennsylvania 

Avenue, NW., Washington, DC 20037. 

Contact Person: Pat Manos, PhD, Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 5200, MSC 7846, Bethesda, MD 

20892, 301–435–1785, manospa@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Oncological Sciences 

Integrated Review Group, Cancer Genetics 

Study Section. 

Date: October 9, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Le Meridien San Francisco, 333 

Baftery Street, San Francisco, CA 94111. 

Contact Person: Zhiqiang Zou, PhD, MD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6190, 

MSC 7804, Bethesda, MD 20892, 301–451– 

0132, zouzhiq@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Biology of 

Development and Aging Integrated Review 

Group Development—1 Study Section. 

Date: October 9–10, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Serrano Hotel, 405 Taylor 

Street, San Francisco, CA 94102. 

Contact Person: Cathy Wedeen, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3213, 

MSC 7808, Bethesda, MD 20892, 301–435– 

1191, wedeenc@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, AcademicIndustry Partnership in Cancer Imaging. 

Date: October 10, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 


jlentini on PROD1PC65 with NOTICES
54410 Federal Register / Vol. 73, No. 183 / Friday, September 19, 2008 / Notices 

Place: Hilton Washington/Rockville, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Xiang-Ning Li, MD, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5112, 

MSC 7854, Bethesda, MD 20892, 301–435– 

1744, lixiang@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, SRO 

Conflict: Biobehavioral Regulation, Learning 

and Ethology. 

Date: October 10, 2008. 

Time: 8 a.m. to 10 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hotel Deca, 4507 Brooklyn Avenue, 

NE., Seattle, WA 98105. 

Contact Person: Biao Tian, PhD, Scientific 

Review Administrator, Center for Scientific 

Review, National Institutes of Health, 6701 

Rockledge Drive, Room 3166, MSC 7848, 

Bethesda, MD 20892, 301–402–4411, 

tianbi@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Mental 

Health and Neurodegenerative Disorders 

Members Conflict. 

Date: October 14, 2008. 

Time: 8 a.m. to 7 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Virtual Meeting) 

Contact Person: Suzan Nadi, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5217B, 

MSC 7846, Bethesda, MD 20892, 301–435– 

1259, nadis@csr.nih.gov. 

Name of Committee: Infectious Diseases 

and Microbiology Integrated, Review Group 

Bacterial Pathogenesis Study Section. 

Date: October 15–16, 2008. 

Time: 8:30 a.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: St. Gregory Hotel, 2033 M Street, 

NW., Washington, DC 20036. 

Contact Person: Richard G. Kostriken, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3192, 

MSC 7808, Bethesda, MD 20892, 301–402– 

4454, kostrikr@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Molecular 

Mechanisms of Neurodegeneration. 

Date: October 15, 2008. 

Time: 9 a.m. to 12:01 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Virtual Meeting) 

Contact Person: Lawrence Baizer, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4152, 

MSC 7850, Bethesda, MD 20892, (301) 435– 

1257, baizerl@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Transplantation, Tolerance, and Tumor 

Immunity: Member Conflicts. 

Date: October 15–16, 2008. 

Time: 10 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Virtual Meeting) 

Contact Person: Stephen M. Nigida, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4212, 

MSC 7812, Bethesda, MD 20892, 301–435– 

1222, nigidas@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Systemic 

Injury by Environmental Exposure. 

Date: October 16, 2008. 

Time: 1 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Residence Inn Bethesda, 7335 

Wisconsin Avenue, Bethesda, MD 20814. 

Contact Person: Peter J. Perrin, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2180, 

MSC 7818, Bethesda, MD 20892, (301) 435– 

0682, perrinp@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Native 

American Research Centers for Health. 

Date: October 20–21, 2008. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Mushtaq A. Khan, DVM, 

PhD, Scientific Review Administrator, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2176, 

MSC 7818, Bethesda, MD 20892, (301) 435– 

1778, khanm@csr.nih.gov. 

Name of Committee: Genes, Genomes, and 

Genetics Integrated Review Group, Ethical, 

Legal, and Social Implications of Human 

Genetics Study Section. 

Date: October 20, 2008. 

Time: 8 a.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Rudy O. Pozzatti, PhD, 

Scientific Review Administrator, Scientific 

Review Branch, National Human Genome 

Research Institute, 5635 Fishers Lane, Suite 

4076, MSC 9306, Rockville, MD 20852, (301) 

402–0838, pozzattr@mail.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Cardiovascular Devices. 

Date: October 20, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Roberto J. Matus, MD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5108, 

MSC 7854, Bethesda, MD 20892, 301–435– 

2204, matusr@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Small 

Business: Biomedical Devices and 

Bioengineering. 

Date: October 20, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Crowne Plaza Hotel Seattle, 1113 

Sixth Avenue, Carlsbad, Seattle, WA 98101. 

Contact Person: Guo Feng Xu, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5122, 

MSC 7854, Bethesda, MD 20892, 301–435– 

1032, xuguofen@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Bioengineering Research Partnerships. 

Date: October 21, 2008. 

Time: 8 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Red Lion Hotel Seattle, 1415 Fifth 

Avenue, Seattle, WA 98101. 

Contact Person: John Firrell, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5213, 

MSC 7854, Bethesda, MD 20892, 301–435– 

2598, firrellj@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Member 

Conflicts: Addiction Prevention and 

Interventions. 

Date: October 21, 2008. 

Time: 3 p.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Virtual Meeting) 

Contact Person: Karen Lechter, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3128, 

MSC 7759, Bethesda, MD 20892, 301–496– 

0726, lechterk@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Topics in 

Virology. 

Date: October 22, 2008. 

Time: 8 a.m. to 7 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: St. Gregory Hotel, 2033 M Street, 

NW., Washington, DC 20036. 

Contact Person: John C. Pugh, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3114, 

MSC 7808, Bethesda, MD 20892, (301) 435– 

2398, pughjohn@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Clinical 

Neurophysiology, Devices, Auditory Devices, 

and Neuroprosthesis Small Business SEP. 

Date: October 22–23, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Holiday Inn Express Hotel and 

Suites, San Francisco Fisherman’s Wharf, 


jlentini on PROD1PC65 with NOTICES
Federal Register / Vol. 73, No. 183 / Friday, September 19, 2008 / Notices 54411 

550 North Point Street, San Francisco, CA 

94133. 

Contact Person: George Ann McKie, DVM, 

PhD, Scientific Review Administrator, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 1124, 

MSC 7846, Bethesda, MD 20892, 301–435– 

1049, mckiegeo@csr.nih.gov. 

Name of Committee: Biology of 

Development and Aging Integrated Review 

Group, International and Cooperative 

Projects—1 Study Section. 

Date: October 23, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Serrano Hotel, 405 Taylor 

Street, San Francisco, CA 94102. 

Contact Person: Manana Sukhareva, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3214, 

MSC 7808, Bethesda, MD 20892, 301–435– 

1116, sukharem@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel. Small 

Business: Medical Imaging. 

Date: October 23–24, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Jurys Washington Hotel, 1500 New 

Hampshire Avenue, NW., Washington, DC 

20036. 

Contact Person: Leonid V. Tsap, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5128, 

MSC 7854, Bethesda, MD 20892, (301) 435– 

2507, tsapl@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Neuropharmacology. 

Date: October 23–24, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Holiday Inn Express Hotel and 

Suites, San Francisco Fisherman’s Wharf, 

550 North Point Street, San Francisco, CA 

91433. 

Contact Person: Aidan Hampson, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5199, 

MSC 7850, Bethesda, MD 20892, (301) 435– 

0634, hampsona@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Chemical 

and Bioanaytical Sciences Fellowships. 

Date: October 23, 2008. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Sergei Ruvinov, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4158, 

MSC 7806, Bethesda, MD 20892, 301–435– 

1180, ruvinser@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, SBIR: Risk 

Prevention and Health Behavior Across the 

Lifespan. 

Date: October 23–24, 2008. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hotel Rouge, 1315 16th Street, 

Washington, DC 20036. 

Contact Person: Claire E. Gutkin, PhD, 

MPH, Scientific Review Administrator, 

Center for Scientific Review, National 

Institutes of Health, 6701 Rockledge Drive, 

Room 3138, MSC 7759, Bethesda, MD 20892, 

301–594–3139, gutkincl@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Alzheimer’s 

Disease Pilot Clinical Trials. 

Date: October 23, 2008. 

Time: 12 p.m.to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892. 

(Telephone Conference Call) 

Contact Person: Alfonso R. Latoni, PhD, 

Scientific Review Administrator, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3182, 

MSC 7848, Bethesda, MD 20892, 301–435– 

0913, latonia@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Visual 

Systems Small Business SEP. 

Date: October 24–25, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Holiday Inn Express Hotel and 

Suites, San Francisco Fisherman’s Wharf, 

550 North Point Street, San Francisco, CA 

94133. 

Contact Person: George Ann McKie, DVM, 

PhD, Scientific Review Administrator, Center 

for Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 1124, 

MSC 7846, Bethesda, MD 20892, 301–435– 

1049, mckiegeo@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: September 11, 2008. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. E8–21808 Filed 9–18–08; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Aging; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel Caloric 

Restriction. 

Date: October 14, 2008. 

Time: 12 p.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Bldg., 7201 Wisconsin Avenue, Rm. 

2C212, Bethesda, MD 20814. (Telephone 

Conference Call) 

Contact Person: Ramesh Vemuri, PhD, 

Chief, Scientific Review Office, National 

Institute on Aging, National Institutes of 

Health, 7201 Wisconsin Avenue, Suite 2C– 

212, Bethesda, MD 20892, 301–402–7700, 

rv23r@nih.gov. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel, Joint Aging 

and Osteoarthritis. 

Date: October 15, 2008. 

Time: 1 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

Suite 2C212, Bethesda, MD 20892. 

(Telephone Conference Call) 

Contact Person: Elaine Lewis, PhD, 

Scientific Review Administrator, Scientific 

Review Office, National Institute on Aging, 

Gateway Building, Suite 2C212, MSC–9205, 

7201 Wisconsin Avenue, Bethesda, MD 

20892, 301–402–7707, 

elainelewis@nia.nih.gov. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel, Sleep and 

Age. 

Date: October 24, 2008 

Time: 1:30 p.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 

2C212, Bethesda, MD 20892. (Telephone 

Conference Call) 

Contact Person: Jeannette L Johnson, PhD, 

Scientific Review Officer, National Institutes 

on Aging, National Institutes of Health, 7201 

Wisconsin Avenue, Suite 2C212, Bethesda, 

MD 20892, 301–402–7705, 

johnsonj9@nia.nih.gov. 

Name of Committee: National Institute on 

Aging Special Emphasis Panel, the 

Somatotropic Axis and Aging. 

Date: November 4, 2008. 

Time: 1 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institute on Aging, 

Gateway Building, 7201 Wisconsin Avenue, 


jlentini on PROD1PC65 with NOTICES